If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern 3 Vct Regulatory News (NTN)

Share Price Information for Northern 3 Vct (NTN)

Share Price is delayed by 15 minutes
Get Live Data
81.00    0.00 (0.00%)
Bid:
79.50
Ask:
82.50
Spread: 3.00 (3.774%)
Market Cap: £144.04m
NTN Live PriceLast checked at - London Stock Exchange

Intraday Northern 3 Vct Share Chart

Interim Results

6 Nov 2008 13:31

RNS Number : 6232H
Northern 3 VCT PLC
06 November 2008
Β 

ο»Ώ

6Β NOVEMBERΒ 2008

NORTHERNΒ 3Β VCTΒ PLC

UNAUDITEDΒ HALF-YEARLY FINANCIAL REPORT FOR THEΒ SIX MONTHSΒ ENDEDΒ 30Β SEPTEMBERΒ 2008

NorthernΒ 3Β VCT PLC is a Venture Capital Trust (VCT) managed byΒ NVM Private Equity. It invests mainly in unquoted venture capital holdings and aims to provide high long-term tax-free returns to shareholders through a combination of dividend yield and capital growth.

Financial highlights:(comparative figuresΒ for the six months endedΒ 30Β SeptemberΒ 2007Β in italics)

2008Β 

2007Β 

Net assets

Β£24.9m

Β£29.5m

Net asset value per share

86.1p

97.9p

Return per share

Revenue

1.5p

1.5p

Capital

(11.8)p

1.4p

Total

(10.3)p

2.9p

Interim dividend per share

in respect of the period

Revenue

1.4p

1.4p

Capital

0.6p

0.6p

Total

2.0p

2.0p

Cumulative returns to

shareholders since launch

Net asset value per share

86.1p

97.9p

Dividends paidΒ per share

18.9p

14.9p

Net asset value plus dividends

paid per share

105.0p

112.8p

Share price at end of period

85.5p

85.0p

For further information, please contact:

NVM Private EquityΒ Limited

Alastair Conn/Christopher Mellor

Website: www.nvm.co.uk

0191 244Β 6000

Lansons Communications

Karen Mignon

020 7294 3685

HALF-YEARLY MANAGEMENT REPORT FOR THE SIX MONTHS ENDED 30Β SEPTEMBERΒ 2008

The period since the publication of the company's last annual report in May 2008 has seen a dramatic deterioration in the state of the world's financial markets, principally due to the unprecedented problems within the banking system. Short-term inflationary pressures have combined with the instability of the markets to create a very difficult trading environment for the smallerΒ unquoted companies in the UK which represent the mainstream of our investment activity,Β and which in many cases are experiencing pressure from their bankers to cope with reduced facilities.

Results

The unaudited net asset value per share at 30 September 2008 was 86.1p, a fall of 10.6% from the audited figure of 96.3p at 31 March 2008. Over the same period the FTSE All-Share index fell by 15.1%. The return per share for the half year was minus 10.3p, compared with a positive return of 2.9p in the corresponding period last year. The cumulative return to shareholders (net asset value plus dividends paid since launch) is 105.0p compared with 112.8p 12 months ago.

The revenue return per share for the half year was unchanged at 1.5p, with a fall in investment income counter-balanced by the exceptional VAT credit referred to below.

The board has declared an unchanged interim dividend of 2.0p per share, comprising a revenue dividend of 1.4p and a capital dividend of 0.6p. The interim dividend will be paid on 17 January 2009 to shareholders on the registerΒ at the close of businessΒ on 12 December 2008.

Investment portfolio

New investment activity in the half year was at a relatively low level, reflecting the increasingly difficult market conditions. Two new venture capital investments totalling Β£1.2 million were completed:

Advanced Computer SoftwareΒ (Β£429,000) - AIM-quoted developer of computer software for the healthcare market, London

CloserStill HoldingsΒ (Β£743,000) - holding company for business-to-business exhibition promoters, London

Small additional investments were made inΒ Britspace HoldingsΒ and the AIM-quotedΒ ISΒ PharmaΒ (formerly known asΒ Maelor).

In May 2008Β Product Support (Holdings)Β was acquired by Wincanton plc in an all-cash deal from which our company realised Β£2.0 million from an original investment of Β£1.0 million, with the possibility of a small further payment to come depending on future performance.

The deterioration in the UK economy has inevitably affected a number of portfolio companies, and the directors' valuation of the unquoted holdings reflects not only trends in profitability but also the general reduction in price-earnings ratios reported in the stock market. In the current climate we believe it is more important than ever to take a conservative view of fair value and several of our investments have been written down to reflect this. The AIM-quoted part of the portfolio has also fallen in value, with the FTSE AIM index down by over 35% during the half year.

It is likely that some of our companies will need further funding to see them through the current downturn, and with the clearing banks seeking to limit their exposure it can be expected that these companies will look to their venture capital backers to provide the bulk of any additional requirement. This may lead to some difficult decisions having to be taken, but where we have a positive view of the quality of management and the strength of future prospects we will be prepared to consider further investment.

Against a background of fluctuations in the corporate bond markets, the portfolio of listed fixed-interest investments managed by Sarasin & Partners LLP was showing an unrealised revaluation deficit of Β£390,000 at 30 September 2008, equivalent to approximately 1.4p per share. It remains our intention to hold most of these stocks to maturity and at this stage we do not expect to realise any significant losses.

Shareholder issues

Following a review of corporate broking arrangements, Landsbanki Securities (formerly Teather & Greenwood) were appointed as brokers to Northern 3 VCT in 2007. They commenced making a market in Northern 3 VCT's shares and assisted the company in implementing itsΒ share buy-backΒ policy. However Landsbanki Securities was adversely affected by the recent well-publicised financial difficulties of its parent group and went into administration in October 2008, as a result of which the firm ceased its market-making activities. There is currently only one remaining market-maker in Northern 3 VCT's shares and the quoted share price has fallen substantially, not helped by the company's inability to deal in its own shares in the close period leading up to the announcement of these half-yearly results.

Your directors understand that a successor firm to Landsbanki Securities, now known as Teathers, expects to resume normal activities imminently under new corporate ownership. We are awaiting confirmation of this before deciding whether to make alternative corporate broking arrangements, and would like to reassure shareholders that the restoration of an orderly market in the company's shares is being given the highest priority.

During the six months to 30 September 2008 the company bought back for cancellation 894,966 shares, representing approximately 3.0% of the issued capital. The directors are considering the possibility of launching a small "top-up" issue of new ordinary shares in the first quarter of 2009 in response to enquiries from shareholders wishing to make a further investment in the company. An announcement concerning this will be made in due course.

VAT on management fees

The Government announced in the 2008 Budget that, with effect from 1 October 2008, investment management fees paid by VCTs would be exempt from VAT. HM Revenue & Customs has subsequently accepted that under European Union VAT law this exemption should have applied from 1 January 1990 onwards, and has indicated that claims may be made for repayment of VAT previously paid by VCTs on management fees, subject to certain restrictive time limits.

At this stage the directors are reasonably certain that the amount of VAT recoverable by Northern 3 VCT will be at least Β£300,000 and an asset of this amount has been recognised in the half-yearly accounts as an exceptional credit in the income statement.

VCT qualifying status

The directors are pleased to report that the company has continued to satisfy HM Revenue & Customs' conditions for the maintenance of approved venture capital trust status. Our managers continue to monitor the position closely with the help of our taxation advisers at PricewaterhouseCoopers LLP.

Board of directors

I would like to take this opportunity to remind shareholders that I will be standing down as chairman of the company in January 2009 and that the directors have invited James Ferguson to become chairman in my place. I will continue to serve as a director and look forward to working with James and our board colleagues in what will undoubtedly be a challenging period ahead.

Prospects

Although the financial markets have shown some signs of stabilising during recent weeks, the outlook for the UK economy appears gloomy for the foreseeable future. This will inevitably have an impact on the performance of our investment portfolio in the short to medium term, notwithstanding that in recent months our overall asset value has held up well by comparison with stock market indices. The company's balance sheet is sound and we have a good reserve of liquidity which will enable us to take advantage of new investment opportunities on a highly selective basis, as well as providing further support to existing investee companies where this is justified by future prospects.

It remains our long-term objective to increase the company's net asset value whilst maintaining a progressive dividend policy through the distribution of both revenue and realised capital gains. This should assist in the development of a more active secondary market in the company's shares. Given the current outlook for theΒ UKΒ economy our managers believe that realisation activity is likely to be subdued for the foreseeable future, and accordingly we will take a prudent approach to the use of our liquid resources.

OnΒ behalf of the Board

John Hustler

Chairman

TheΒ unauditedΒ half-yearly financial statements for theΒ six monthsΒ endedΒ 30Β SeptemberΒ 2008Β are set out below.

INCOME STATEMENT

(unaudited)Β for theΒ six monthsΒ endedΒ 30Β SeptemberΒ 2008

Six months ended

30Β SeptemberΒ 2008

Six months ended

30Β SeptemberΒ 2007

RevenueΒ 

Β£000Β 

CapitalΒ 

Β£000Β 

TotalΒ 

Β£000Β 

RevenueΒ 

Β£000Β 

CapitalΒ 

Β£000Β 

TotalΒ 

Β£000Β 

Gain on disposal ofΒ investments

-Β 

458Β 

458Β 

-Β 

427Β 

427Β 

Movements inΒ fair valueΒ of investments

-Β 

(3,917)

(3,917)

-Β 

173Β 

173Β 

------Β 

------Β 

------Β 

------Β 

------Β 

------Β 

-Β 

(3,459)

(3,459)

-Β 

600Β 

600Β 

Income

686Β 

-Β 

686Β 

799Β 

-Β 

799Β 

Investment management fee

(78)

(234)

(312)

(87)

(260)

(347)

Recoverable VAT

72Β 

228Β 

300Β 

-Β 

-Β 

-Β 

Other expenses

(109)

-Β 

(109)

(101)

-Β 

(101)

------Β 

------Β 

------Β 

------Β 

------Β 

------Β 

Return on ordinary activities

before tax

571Β 

(3,465)

(2,894)

611Β 

340Β 

951Β 

Tax on return on ordinary activities

(128)

-Β 

(128)

(167)

84Β 

(83)

------Β 

------Β 

------Β 

------Β 

------Β 

------Β 

Return on ordinary activities

after taxΒ 

443Β 

(3,465)

(3,022)

444Β 

424Β 

868Β 

------Β 

------Β 

------Β 

------Β 

------Β 

------Β 

Return per share

1.5p

(11.8)p

(10.3)p

1.5p

1.4p

2.9p

18 monthsΒ ended

31Β MarchΒ 2008

RevenueΒ 

Β£000Β 

CapitalΒ 

Β£000Β 

TotalΒ 

Β£000Β 

Gain on disposal of investments

-Β 

85Β 

85Β 

MovementsΒ inΒ fair valueΒ of investments

-Β 

1,969Β 

1,969Β 

------Β 

------Β 

------Β 

-Β 

2,054Β 

2,054Β 

Income

2,228Β 

-Β 

2,228Β 

Investment management fee

(259)

(903)

(1,162)

Recoverable VAT

-Β 

-Β 

-Β 

Other expenses

(295)

-Β 

(295)

------Β 

------Β 

------Β 

Return on ordinary activities

before tax

1,674Β 

1,151Β 

2,825Β 

Tax on return on ordinary activities

(441)

271Β 

(170)

------Β 

------Β 

------Β 

Return on ordinary activities

after taxΒ 

1,233Β 

1,422Β 

2,655Β 

------Β 

------Β 

------Β 

Return per share

4.1p

4.7p

8.8p

RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS

(unaudited) for the six months endedΒ 30Β SeptemberΒ 2008

Six months ended

30Β SeptemberΒ 2008

Six months ended

30Β SeptemberΒ 2007

18 monthsΒ ended

31Β MarchΒ 2008

Β£000Β 

Β£000Β 

Β£000Β 

Equity shareholders' funds at

1Β AprilΒ 2008

28,645Β 

29,492Β 

29,281Β 

Return on ordinary activities after tax

(3,022)

868Β 

2,655Β 

Dividends recognised in the period

3Β 

(603)

(2,418)

Net proceeds of share issues

-Β 

69Β 

287Β 

Shares purchased for cancellation

(772)

(304)

(1,142)

Expenses charged to capital reserve

-Β 

(18)

(18)

------Β 

------Β 

------Β 

Equity shareholders' funds at

30Β SeptemberΒ 2008

24,854Β 

29,504Β 

28,645Β 

------Β 

------Β 

------Β 

BALANCE SHEET

(unaudited)Β as atΒ 30Β SeptemberΒ 2008

30Β SeptemberΒ 2008Β 

30Β SeptemberΒ 2007Β 

31Β MarchΒ 2008

Β£000Β 

Β£000Β 

Β£000Β 

Fixed asset investments:

Venture capital investments

Unquoted

13,778Β 

16,089Β 

17,852Β 

Quoted

1,910Β 

2,487Β 

1,851Β 

------Β 

------Β 

------Β 

TotalΒ venture capital investments

15,688Β 

18,576Β 

19,703Β 

Listed fixed-interest investments

7,423Β 

9,382Β 

7,497Β 

------Β 

------Β 

------Β 

Total fixed asset investments

23,111Β 

27,958Β 

27,200Β 

------Β 

------Β 

------Β 

Current assets:

Debtors

566Β 

463Β 

265Β 

Cash at bank

1,385Β 

1,250Β 

1,526Β 

------Β 

------Β 

------Β 

1,951Β 

1,713Β 

1,791Β 

Creditors (amounts due within one year)

(208)

(167)

(346)

------Β 

------Β 

------Β 

Net current assets

1,743Β 

1,546Β 

1,445Β 

------Β 

------Β 

------Β 

Net assets

24,854Β 

29,504Β 

28,645Β 

------Β 

------Β 

------Β 

Capital and reserves:

Called-up equity share capital

1,443Β 

1,506Β 

1,487Β 

Share premium

8,031Β 

7,893Β 

8,031Β 

Capital redemption reserve

188Β 

116Β 

143Β 

Capital reserve - realised

15,779Β 

17,413Β 

15,997Β 

Capital reserve - unrealised

(1,270)

1,847Β 

2,749Β 

Revenue reserve

683Β 

729Β 

238Β 

------Β 

------Β 

------Β 

Total equity shareholders' funds

24,854Β 

29,504Β 

28,645Β 

------Β 

------Β 

------Β 

Net asset value per share

86.1p

97.9p

96.3p

CASH FLOW STATEMENT

(unaudited)Β for theΒ six monthsΒ endedΒ 30Β SeptemberΒ 2008

Six months endedΒ 

30Β SeptemberΒ 2008Β 

Six months endedΒ 

30Β SeptemberΒ 2007Β 

18 monthsΒ endedΒ 

31Β MarchΒ 2008Β 

Β£000Β 

Β£000Β 

Β£000Β 

Β£000Β 

Β£000Β 

Β£000Β 

Net cashΒ inflowΒ from

operating activities

113Β 

295Β 

1,206Β 

Taxation:

Corporation tax paid

(115)

-Β 

(105)

Financial investment:

Purchase of investments

(4,246)

(7,077)

(16,041)

Sale/repayment of investments

4,876Β 

7,018Β 

16,133Β 

------Β 

------Β 

------Β 

Net cashΒ inflow/(outflow)

fromΒ financial investment

630Β 

(59)

92Β 

Equity dividends paid

3Β 

(603)

(2,418)

------Β 

------Β 

------Β 

Net cashΒ inflow/(outflow)

before financing

631Β 

(367)

(1,225)

Financing:

Issue of ordinary shares

-Β 

74Β 

293Β 

Share issue expenses

-Β 

(5)

(6)

Purchase of ordinary shares

for cancellation

(772)

(304)

(1,142)

------Β 

------Β 

------Β 

Net cashΒ outflowΒ from financing

(772)

(235)

(855)

------Β 

------Β 

------Β 

Decrease in cash at bank

(141)

(602)

(2,080)

------Β 

------Β 

------Β 

Reconciliation of return before

taxΒ to net cash flow from

operating activities

Return on ordinary activities

before tax

(2,894)

951Β 

2,825Β 

Gain on disposal of investments

(458)

(427)

(85)

Movements inΒ fair value

of investments

3,917Β 

(173)

(1,969)

(Increase)/decrease in debtors

(301)

(33)

335Β 

Increase/(decrease) in creditors

(151)

(5)

118Β 

Expenses charged to capital

-Β 

(18)

(18)

------Β 

------Β 

------Β 

Net cashΒ inflow from

operating activities

113Β 

295Β 

1,206Β 

------Β 

------Β 

------Β 

Analysis of movement in net funds

1Β AprilΒ 2008

Cash flowsΒ 

30Β SeptemberΒ 2008

Β£000

Β£000Β 

Β£000

Cash at bank

1,526Β 

(141)

1,385Β 

------Β 

------Β 

------Β 

INVESTMENT PORTFOLIO SUMMARY

as atΒ 30Β SeptemberΒ 2008

Cost

Β£000

Valuation

Β£000

% of net assets

by valuation

15 largestΒ investments:

Pivotal Laboratories Holdings

679

1,045

4.2

Paladin Group

860

1,038

4.2

Optilan Group

1,000

1,000

4.0

Axial Systems Holdings

1,000

1,000

4.0

Envirotec

456

867

3.5

Promanex Group Holdings

1,000

750

3.0

CloserStill Holdings

743

743

3.0

DxS

325

615

2.5

Promatic Group

568

568

2.3

Frontier Foods

542

542

2.2

Crantock Bakery

442

522

2.1

Abermed

375

502

2.0

Astbury Marsden Holdings

1,000

500

2.0

Britspace Holdings

588

473

1.9

Arleigh International

210

473

1.9

------

------

-----

9,788

10,638

42.8

Other venture capital investments

7,170

5,050

20.3

------

------

-----

Total venture capital investments

16,958

15,688

63.1

Listed fixed-interest investments

7,813

7,423

29.9

------

------

-----

Total fixed asset investments

24,771

23,111

93.0

------

Net current assets

1,743

7.0

------

-----

Net assets

24,854

100.0

------

-----

The above half-yearly financial statements for the six months ended 30Β SeptemberΒ 2008 do not constitute statutory financial statements within the meaning of Section 240 of the Companies Act 1985 and have not been delivered to the Registrar of Companies. The figures for theΒ 18 monthsΒ ended 31Β MarchΒ 2008Β have been extracted from the audited financial statements for thatΒ period, which have been delivered to the Registrar of Companies; the independent auditors' report on those financial statements under Section 235 of the Companies Act 1985 was unqualified. The half-yearly financial statements have been prepared on the basis of the accounting policies set out in the financial statements for theΒ 18 monthsΒ ended 31Β MarchΒ 2008.

The directors confirm that to the best of their knowledge the half-yearly financial statements have been prepared in accordance with the Statement "Half-yearly financial reports" issued by the UK Accounting Standards Board and the half-yearly financial report includes a fair review of the information required by (a) DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the year, and (b) DTR 4.2.8R of the Disclosure and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period, and any changes in the related party transactions described in the last annual report that could do so.

The calculation of the revenue and capital return per share is based on the return on ordinary activities after tax for the period and onΒ 29,376,116Β (2007Β 30,477,836) ordinary shares, being the weighted average number of shares in issue during the period.

The proposed interim dividend ofΒ 2.0p per share for the year ending 31Β MarchΒ 2009 will be paid onΒ 17Β January 2009Β to shareholders on the register at the close of business onΒ 12 December 2008.

A copy of the half-yearly financial report for the six months ended 30Β SeptemberΒ 2008 is expected to be posted to shareholders onΒ 21Β November 2008Β and will be available to the public at the registered office of the company at Northumberland House, Princess Square, Newcastle upon Tyne NE1 8ER and on the NVM Private Equity Limited website, www.nvm.co.uk.

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR FSWFDMSASEEF
Date   Source Headline
30th Nov 20212:00 pmGNWStatement regarding intention to fund raise
24th Nov 20214:25 pmGNWHalf-year report
31st Aug 20217:45 pmGNWTotal voting rights
27th Aug 202110:15 amGNWIssue of Equity
19th Aug 20211:00 pmGNWResult of AGM
20th Jul 20214:00 pmGNWNet Asset Value
20th Jul 20213:45 pmGNWAnnual Financial Report
19th Jul 20213:00 pmGNWStatement re intention to fund raise
5th Jul 202112:45 pmGNWTransaction in Own Shares
23rd Jun 20213:00 pmGNWAnnual Financial Report
22nd Apr 20219:00 amGNWAdmission to AIM of musicMagpie plc
8th Apr 202111:35 amGNWInvestee company - intention to float
1st Apr 20212:30 pmGNWTotal voting rights
30th Mar 20213:45 pmGNWTransaction in Own Shares
8th Mar 202112:45 pmGNWTransaction in Own Shares
25th Feb 20215:20 pmGNWNet Asset Value(s)
1st Feb 20214:50 pmGNWTotal voting rights
29th Jan 202110:00 amGNWIssue of Equity
22nd Dec 20201:30 pmGNWHalf-year report
18th Dec 20204:00 pmGNWTransaction in Own Shares
1st Dec 20204:20 pmGNWHalf-year report
30th Sep 20205:00 pmGNWTotal voting rights
28th Sep 20205:50 pmGNWTransaction in Own Shares
15th Sep 20204:00 pmGNWDirectorate change
4th Sep 202011:50 amGNWDirector/PDMR Shareholding
4th Sep 202011:45 amGNWIssue of Equity
27th Aug 20201:30 pmGNWResult of AGM
31st Jul 20202:30 pmGNWNet Asset Value
31st Jul 20202:30 pmGNWTotal voting rights
28th Jul 20203:30 pmGNWAnnual Financial Report
16th Jul 202012:00 pmGNWTransaction in Own Shares
8th Jul 20204:25 pmGNWAnnual Financial Report
17th Jun 202012:00 pmGNWPublication of updated and amended reporting timetable
30th Apr 20204:00 pmGNWTotal Voting Rights
14th Apr 20202:00 pmGNWIssue of Equity
6th Apr 20202:30 pmGNWDirector/PDMR Shareholding
6th Apr 20202:30 pmGNWDirector/PDMR Shareholding
6th Apr 20202:30 pmGNWDirector/PDMR Shareholding
3rd Apr 202012:30 pmGNWIssue of Equity
2nd Apr 202010:00 amGNWUpdate re share offer
1st Apr 20201:15 pmGNWStatement re extension of share offer period
31st Mar 20204:30 pmGNWTotal voting rights
31st Mar 20204:00 pmGNWPublication of a supplementary prospectus
30th Mar 202011:35 amGNWTransaction in Own Shares
25th Mar 20202:50 pmGNWNet Asset Value(s)
25th Feb 20203:32 pmGNWTransaction in Own Shares
17th Feb 20203:00 pmGNWNet Asset Value(s)
31st Jan 20204:00 pmGNWTotal voting rights
24th Jan 20202:00 pmGNWStatement re Issue of Equity and total voting rights
24th Jan 202012:30 pmGNWDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.